Reagent polynucleotide complex with multiple target binding regions, and kit and methods

• US 4,725,536 A
• Filed: 09/19/1985
• Issued: 02/16/1988
• Est. Priority Date: 09/19/1985
• Status: Expired due to Fees

• Current Assignee: Genetics Institute LLC (Pfizer Inc.)
• Original Assignee: Genetics Institute LLC (Pfizer Inc.)
• Inventors: Collins, Mary, Fritsch, Edward F.
• Primary Examiner(s): Warden, Robert J.
• Assistant Examiner(s): Spiegel, Jack
• Application Number:
  US06/777,796
• Time in Patent Office: 880 Days
• Field of Search: 435/6, 435/810, 436/501, 935/77, 935/78, 536/27, 536/28, 536/26
• US Class Current: 435/6.11
• CPC Class Codes: C12Q 1/6823 Release of bound markers
• CPC Class Codes: C12Q 1/6827 for detection of mutation or polymorphism
• CPC Class Codes: C12Q 1/6883 for diseases caused by alterations of genetic material
• CPC Class Codes: Y10S 435/81 Packaged device or kit

Abstract

Reagent complexes containing a probe polynucleotide with at least two target binding regions. A labeled polynucleotide is bound to at least a portion of each target binding region. In one method, sample nucleic acid displaces labeled polynucleotide from one target binding region; after washing, a reagent polynucleotide displaces labeled polynucleotide from the other target binding region. In a second method, sample nucleic acid strands having two target nucleic acid sequences in proximity (e.g., sequences translocated in certain cancers) displace the labeled polynucleotide from both target binding region.

Claims

1. A reagent complex for the determination of a predetermined target nucleotide sequence in the nucleic acid of a biological sample comprising:

(a) a probe polynucleotide having;

(i) a first target binding region which is capable of complementary base pair binding via hydrogen bonds of purine/pyrimidine base pairs to a target nucleotide sequence; and

(ii) a second target binding region which is capable of complementary base pair binding via hydrogen bonds of purine/pyrmimdine base pairs to a selected nucleotide sequence; and

(b) a labeled polynucleotide which is bound by complementary base pair binding via hydrogen bonds of purine/pyrimidine base pairs to the probe polynucleotide in at least a portion of the first target binding region and in at least a portion of the second target binding region.

2. The reagent complex of claim 1 wherein the selected nucleotide sequence is present in a biological sample in varying degrees of proximity to the target nucleotide sequence.

3. The reagent complex of claim 2 wherein the target nucleotide sequence and selected nucleotide sequence are chromosomal DNA sequences whose relative position changes with disease states.

4. The reagent complex of claim 3 wherein the target nucleotide sequence and selected nucleotide sequence are normally on separate chromosomes but, in a disease state, are on a common chromosome.

5. The reagent complex of claim 3 wherein the target nucleotide sequence and selected nucleotide sequence are normally on a common chromosome but, in a disease state, are on separate chromosomes.

6. The reagent complex of claim 3 wherein the target nucleotide sequence is a constant region and the selected nucleotide sequence is a variable region of chromosomal DNA.

7. The reagent complex of claim 2 wherein the target nucleotide sequence and selected nucleotide sequence are messenger RNA sequences.

8. A diagnostic kit comprising the reagent complex of claim 1 and a polynucleotide reagent containing the selected nucleotide sequence.

9. The diagnostic kit of claim 8 wherein the probe polynucleotide is immobilized in the reagent complex.

10. The diagnostic kit of claim 8 wherein the probe polynucleotide contains a moiety immobilized by an affinity reagent and the kit further comprises an immobilized affinity reagent for the moiety.

11. The diagnostic kit of claim 8 wherein the target nucleotide sequence and selected nucleotide sequence are present on a common polynucleotide strand in samples from normal individuals, but are present on separate polynucleotide strands in the event of a translocation.

12. The reagent complex of claim 1 wherein the probe polynucleotide has a third target nucleotide sequence and the labeled polynucleotide is further bound by complementary base pair binding to at least a portion of the third target nucleotide sequence.

13. A method for the determination of a predetermined target nucleotide sequence in the nucleic acid of a biological sample comprising the steps:

(I) contacting the sample with a reagent complex comprising;

(a) a probe polynucleotide having;

(i) a first target binding region which is capable of complementary base pair binding via hydrogen bonds of purine/pyrimidine base pairs to the target nucleotide sequence; and

(ii) a second target binding region which is capable of complementary base pair binding via hydrogen bonds of purine/pyrimidine base pairs to a selected nucleotide sequence; and

(b) a labeled polynucleotide which is bound by complementary base pair binding via hydrogen bonds of purine/pyrimidine base pairs to the probe polynucleotide in at least a portion of the first target binding region and in at least a portion of the second target nucleotide sequence,

under conditions in which the target nucleotide sequence, if present, displaces the labeled polynucleotide from the first target binding region;

(II) washing the reagent complex;

(III) further contacting the washed reagent complex with a polynucleotide reagent comprising the selected nucleotide sequence under conditions in which the selected nucleotide sequence displaces the labeled polynucleotide from the second target binding region; and

(IV) detecting labeled polynucleotide displaced from the first and second target binding regions.

14. The method of claim 13 wherein the probe polynucleotide is immobilized in the reagent complex.

15. The method of claim 13 wherein the reagent complex is in solution during the contacting step (I) and the probe polynucleotide contains a moiety immobilizable by an affinity reagent.

16. The method of claim 15 wherein the washing step (II) comprises first immobilizing the reagent complex with an immobilized affinity reagent for the moiety and then washing.

20. The method of claim 16 wherein the target nucleotide sequence and selected nucleotide sequence are chromosomal DNA sequences whose relative position changes with disease states.

21. The method of claim 16 wherein the target nucleotide sequence and selected nucleotide sequence are messenger RNA sequences.

17. A method for determining the presence of a target nucleotide sequence and a selected nucleotide sequence within a common polynucleotide strand of the nucleic acid of a biological sample, which comprises the steps:

(I) contacting the sample with a reagent complex comprising;

(a) a probe polynucleotide having;

(i) a first target binding region which is capable of complementary base pairing binding via hydrogen bonds of purine/pyrimidine base pairs to the target nucleotide sequence; and

(ii) a second target binding region which is capable of complementary base pair binding via hydrogen bonds of purine/pyrimidine base pairs to a selected nucleotide sequence; and

(b) a labeled polynucleotlde which is bound by complementary base pair binding via hydrogen bonds of purine/pyrimidine base pairs to the probe polynucleotide in at least a portion of the first target binding region and in at least a portion of the second target nucleotide sequence;

under conditions, including sufficient molar excess of reagent complex relative to anticipated levels of the target nucleotide sequence and of the selected nucleotide sequence, under which sample nucleic acid strands having the target nucleotide sequence and the selected nucleotide sequence, if present within a common sample polynucleotide strand, will displace substantially more labeled polynucleotide strands from the first and second target binding regions of a common probe strand than will target nucleotide sequence and selected nucleotide sequence on separate sample polynucleotide strands; and

(II) detecting labeled polynucleotide displaced from the first and second target binding regions of a common probe strand.

18. The method of claim 17 wherein the molar ratio of reagent complex to either the anticipated level of target nucleotide sequence or selected nucleotide sequence, whichever is higher, is at least about 100:

1.

19. The method of claim 17 wherein the ratio is between about 10³ :

1 and about 10⁶ ;

1.